{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:22:37Z","timestamp":1791426157247,"version":"4.3.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.micpath.2021.104746","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T20:37:17Z","timestamp":1611261437000},"page":"104746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A novel approach for an immunogen against Corynebacterium pseudotuberculosis infection: An Escherichia coli bacterin expressing phospholipase D"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-352X","authenticated-orcid":false,"given":"Rodrigo","family":"Barros de Pinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara Thais","family":"de Oliveira Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8119-9431","authenticated-orcid":false,"given":"Gabriel","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna Samara","family":"Di\u00e9 Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Dias Portela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibele","family":"Borsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104746_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1051\/vetres:2005056","article-title":"Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence","volume":"37","author":"Dorella","year":"2006","journal-title":"Vet. Res."},{"key":"10.1016\/j.micpath.2021.104746_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-017-0925-6","article-title":"A shift in the virulence potential of Corynebacterium pseudotuberculosis biovar ovis after passage in a murine host demonstrated through comparative proteomics","volume":"17","author":"Silva","year":"2017","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2021.104746_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/1177932218755337","article-title":"Immune-informatic analysis and design of peptide vaccine from multi-epitopes against Corynebacterium pseudotuberculosis","volume":"12","author":"Droppa-Almeida","year":"2018","journal-title":"Bioinform. Biol. Insights"},{"key":"10.1016\/j.micpath.2021.104746_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcpa.2007.07.002","article-title":"Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis","volume":"137","author":"Baird","year":"2007","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.micpath.2021.104746_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/14760584.8.2.205","article-title":"Antigens of Corynebacterium pseudotuberculosis and prospects for vaccine development","volume":"8","author":"a Dorella","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2021.104746_bib6","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1099\/mic.0.2007\/005926-0","article-title":"Expression of phospholipase D, the major virulence factor of Corynebacterium pseudotuberculosis is regulated by multiple environmental factors and plays a role in macrophage death","volume":"153","author":"McKean","year":"2007","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2021.104746_bib7","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1128\/iai.62.12.5275-5280.1994","article-title":"Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant corynebacterium protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis","volume":"62","author":"Hodgson","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.104746_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1085\/jgp.201511359","article-title":"Sphingomyelinase D inhibits store-operated Ca 2+ entry in T lymphocytes by suppressing ORAI current","volume":"146","author":"Combs","year":"2015","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.micpath.2021.104746_bib9","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/iai.60.7.2900-2905.1992","article-title":"Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle","volume":"60","author":"Hodgson","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.104746_bib10","first-page":"129","article-title":"Vaccinal efficacy of genetically inactivated phospholipase D against caseous lymphadenitis in small ruminants","volume":"1","author":"Sa","year":"2010","journal-title":"Int. J. Microbiol. Res."},{"key":"10.1016\/j.micpath.2021.104746_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.vaccine.2017.11.029","article-title":"Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis","volume":"36","author":"Silva","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104746_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.anaerobe.2016.05.012","article-title":"Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D","volume":"40","author":"Moreira","year":"2016","journal-title":"Anaerobe"},{"key":"10.1016\/j.micpath.2021.104746_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tvjl.2007.11.009","article-title":"Veterinary vaccine development from an industrial perspective","volume":"178","author":"Heldens","year":"2008","journal-title":"Vet. J."},{"key":"10.1016\/j.micpath.2021.104746_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins10100381","article-title":"Immunogenicity of a bivalent non-purified recombinant vaccine against botulism in cattle","volume":"10","author":"Moreira","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.micpath.2021.104746_bib15","first-page":"333","article-title":"Production of recombinant proteins by microbes and higher organisms","volume":"3","author":"Demain","year":"2011","journal-title":"Compr. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104746_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3382\/ps.2007-00481","article-title":"Additions of killed whole cell bacteria preparations to Freund complete adjuvant alter laying hen antibody response to soluble protein antigen","volume":"87","author":"Trott","year":"2008","journal-title":"Poultry Sci."},{"key":"10.1016\/j.micpath.2021.104746_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vetmic.2019.01.017","article-title":"Establishment of an objective endpoint in mice model for caseous lymphadenitis vaccine trials","volume":"230","author":"Silva","year":"2019","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2021.104746_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1099\/jmm.0.000477","article-title":"Recombinant esterase from Corynebacterium pseudotuberculosis in DNA and subunit recombinant vaccines partially protects mice against challenge","volume":"66","author":"Brum","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2021.104746_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1874318809003010022","article-title":"Immunization with recombinant Corynebacterium pseudotuberculosis Heat-Shock Protein (Hsp)-60 is able to induce an immune response in mice, but fails to confer protection against infection","volume":"3","author":"Pinho","year":"2009","journal-title":"Open Vet. Sci. J."},{"key":"10.1016\/j.micpath.2021.104746_bib20","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.vaccine.2015.12.064","article-title":"Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain","volume":"34","author":"Droppa-Almeida","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104746_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1186\/s12917-014-0304-6","article-title":"Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis","volume":"10","author":"Silva","year":"2014","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.micpath.2021.104746_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199208133270702","article-title":"A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children","volume":"327","author":"Werzberger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2021.104746_bib23","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","article-title":"Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104746_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/bit.10018","article-title":"Metabolic oscillations in an E. Coli fermentation","volume":"75","author":"Andersen","year":"2001","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.micpath.2021.104746_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/IAI.01533-13","article-title":"Oral immunization with escherichia coli expressing a lipidated form of LigA protects hamsters against challenge with leptospira interrogans serovar Copenhageni","volume":"82","author":"Lourdault","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2021.104746_bib26","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/j.vaccine.2018.05.049","article-title":"BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain","volume":"36","author":"Leal","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104746_bib27","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.sjbs.2016.06.005","article-title":"Vaccination against Corynebacterium pseudotuberculosis infections controlling caseous lymphadenitis (CLA) and oedematous skin disease","volume":"23","author":"Moussa","year":"2016","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.micpath.2021.104746_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.vetimm.2008.06.013","article-title":"Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canind\u00e9 goats and their potential protection against in Caninde caseous lymphadenitis","volume":"126","author":"Moura-costa","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.micpath.2021.104746_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0264-410X(94)90013-2","article-title":"Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells","volume":"12","author":"Lipford","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104746_bib30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2021.104746_bib31","first-page":"329","volume":"vol. 6","author":"Dong","year":"2006"},{"key":"10.1016\/j.micpath.2021.104746_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00121","article-title":"Next-generation vaccines based on Bacille Calmette \u2013 Gu\u00e9rin","volume":"9","author":"Nieuwenhuizen","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2021.104746_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed by human and mice-specific CD4+ and CD8+ T cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2021.104746_bib34","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1202722","article-title":"IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection","author":"Cyktor","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2021.104746_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molimm.2017.02.017","article-title":"Time-dependent effect of E. coli LPS in spleen DC activation in vivo: alteration of numbers , expression of co-stimulatory molecules , production of pro-inflammatory cytokines , and presentation of antigens","volume":"85","author":"Xu","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2021.104746_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/08830185.2017.1380200","article-title":"International Reviews of Immunology Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals","author":"Vidya","year":"2018","journal-title":"Int. Rev. Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:58Z","timestamp":1760110318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":36,"alternative-id":["S0882401021000188"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104746","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel approach for an immunogen against Corynebacterium pseudotuberculosis infection: An Escherichia coli bacterin expressing phospholipase D","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104746"}}